Oncaspar (pegaspargase) NDC 72694-954

NDC codes

FDA NDC Directory

Product NDC (as listed)72694-954Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72694-0954Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72694-954-01	72694095401	1 VIAL, SINGLE-USE in 1 CARTON (72694-954-01) / 5 mL in 1 VIAL, SINGLE-USEMarketed from Jan 2, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oncaspar
Generic name (nonproprietary): pegaspargase
Active ingredients: Pegaspargase — 750 [iU]/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Servier Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 103411
Marketing start: Jan 2, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Asparaginase (Chemical structure)
Identifiers: Product ID 72694-954_f0a8a9ab-8203-47aa-abbe-54614c201d48SPL ID f0a8a9ab-8203-47aa-abbe-54614c201d48SPL set ID ac7b6a6f-6ddb-48c6-8088-d8a8e3fea6ceRxCUI 213040, 240906UNII 7D96IR0PPM
Pharmacologic class: Asparagine-specific Enzyme

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472694095401 followed by a unit qualifier and the quantity

Package 72694-0954-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 7, 2024.

Indications (excerpt from the label)

ONCASPAR is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for treatment of pediatric and adult patients with: First-line acute lymphoblastic leukemia ( 1.1 ) Acute lymphoblastic leukemia and hypersensitivity to asparaginase ( 1.2 ) 1.1 First Line Acute Lymphoblastic Leukemia (ALL) ONCASPAR ® is indicated as a component of a multi-agent chemotherapeutic regimen for the first-line treatment of pediatric and adult patients with ALL. 1.2 Acute Lymphoblastic Leukemia and Hypersensitivity to Asparaginase ONCASPAR is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of pediatric and adult patients with ALL and hyp…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)